Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Urachal remnant infection leading to Pseudomonas aeruginosa bacteremia in induction therapy for adult B-cell acute lymphoblastic leukemia.

Nakazato T, Suzuki K, Mihara A, Sanada Y, Aisa Y, Kakimoto T, Moriyama M.

Int J Hematol. 2011 Sep;94(3):298-9. doi: 10.1007/s12185-011-0911-y. Epub 2011 Aug 20. No abstract available.

PMID:
21858444
2.

Ecthyma gangrenosum: sign of Pseudomonas aeruginosa bacteremia.

Demircioğlu F, Oren H.

Pediatr Hematol Oncol. 2008 Jun;25(4):369-70. doi: 10.1080/08880010802016102. No abstract available.

PMID:
18484484
3.

Successful treatment of multi-resistant Pseudomonas aeruginosa osteomyelitis after allogeneic bone marrow transplantation with a combination of colistin and tigecycline.

Stanzani M, Tumietto F, Giannini MB, Bianchi G, Nanetti A, Vianelli N, Arpinati M, Giovannini M, Bonifazi F, Bandini G, Baccarani M.

J Med Microbiol. 2007 Dec;56(Pt 12):1692-5.

PMID:
18033842
4.

[On the way to optimal Pseudomonas aeruginosa bacteriemia therapy].

Cobo Reinoso J, Moreno Guillén S.

Rev Clin Esp. 2004 Sep;204(9):445-7. Spanish. No abstract available.

PMID:
15388016
5.

Recent experience with Pseudomonas aeruginosa bacteremia in patients with cancer: Retrospective analysis of 245 episodes.

Chatzinikolaou I, Abi-Said D, Bodey GP, Rolston KV, Tarrand JJ, Samonis G.

Arch Intern Med. 2000 Feb 28;160(4):501-9.

PMID:
10695690
6.

Improved prognosis of Pseudomonas aeruginosa bacteremia in 127 consecutive neutropenic patients with hematologic malignancies.

Todeschini G, Franchini M, Tecchio C, Meneghini V, Pizzolo G, Veneri D, Murari C, Ricetti MM, Perona G.

Int J Infect Dis. 1998-1999 Winter;3(2):99-104.

PMID:
10225988
7.

[Successful combination therapy by meropenem and colistin for multi-drug-resistant Pseudomonas aeruginosa infection after allogeneic bone marrow transplantation].

Kanda M, Shigematsu A, Okada K, Kasahara I, Iwasaki J, Yamaguchi K, Onozawa M, Endo T, Akizawa K, Ishiguro N, Hashino S, Imamura M.

Rinsho Ketsueki. 2011 Mar;52(3):118-23. Japanese.

PMID:
21471698
8.

Impact of inappropriate empiric antimicrobial therapy on outcome in Pseudomonas aeruginosa bacteraemia: a stratified analysis according to sites of infection.

Joo EJ, Kang CI, Ha YE, Park SY, Kang SJ, Wi YM, Lee NY, Chung DR, Peck KR, Song JH.

Infection. 2011 Aug;39(4):309-18. doi: 10.1007/s15010-011-0124-6. Epub 2011 May 19.

PMID:
21594653
9.

Review of the incidence and prognosis of Pseudomonas aeruginosa infections in cancer patients in the 1990s.

Maschmeyer G, Braveny I.

Eur J Clin Microbiol Infect Dis. 2000 Dec;19(12):915-25. Review.

PMID:
11205628
10.

Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection.

Suárez C, Peña C, Gavaldà L, Tubau F, Manzur A, Dominguez MA, Pujol M, Gudiol F, Ariza J.

Int J Infect Dis. 2010 Sep;14 Suppl 3:e73-8. doi: 10.1016/j.ijid.2009.11.019. Epub 2010 Mar 11.

12.

Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality.

Vitkauskienė A, Skrodenienė E, Dambrauskienė A, Macas A, Sakalauskas R.

Medicina (Kaunas). 2010;46(7):490-5.

13.

Pseudomonas aeruginosa bacteremia: an analysis of 123 episodes, with particular emphasis on the effect of antibiotic therapy.

Siegman-Igra Y, Ravona R, Primerman H, Giladi M.

Int J Infect Dis. 1998 Apr-Jun;2(4):211-5.

PMID:
9763504
14.

Acrodermatitis enteropathica with Pseudomonas aeruginosa sepsis.

Ozkan S, Ozkan H, Fetil E, Corapçioglu F, Yilmaz S, Ozer E.

Pediatr Dermatol. 1999 Nov-Dec;16(6):444-7.

PMID:
10632941
15.

Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1.

Vidal F, Mensa J, Martínez JA, Almela M, Marco F, Gatell JM, Richart C, Soriano E, Jiménez de Anta MT.

Eur J Clin Microbiol Infect Dis. 1999 Jul;18(7):473-7.

PMID:
10482023
16.

Endogenous Pseudomonas endophthalmitis in an immunocompetent patient.

Diaz-Valle D, Benitez del Castillo JM, Fernandez Acenero MJ, Santos-Bueso E, Martinez de la Casa JM, Garcia-Sanchez J.

Eur J Ophthalmol. 2007 May-Jun;17(3):461-3.

PMID:
17534838
17.

Inappropriate initial antimicrobial therapy as a risk factor for mortality in patients with community-onset Pseudomonas aeruginosa bacteraemia.

Cheong HS, Kang CI, Wi YM, Ko KS, Chung DR, Lee NY, Song JH, Peck KR.

Eur J Clin Microbiol Infect Dis. 2008 Dec;27(12):1219-25. doi: 10.1007/s10096-008-0568-5. Epub 2008 Jun 25.

PMID:
18575908
18.

Impact of AmpC overexpression on outcomes of patients with Pseudomonas aeruginosa bacteremia.

Tam VH, Chang KT, Schilling AN, LaRocco MT, Genty LO, Garey KW.

Diagn Microbiol Infect Dis. 2009 Mar;63(3):279-85. doi: 10.1016/j.diagmicrobio.2008.11.007. Epub 2009 Jan 8.

PMID:
19135330
19.

[Clinical approach to infection in patients with hematologic malignancy].

Funada H.

Gan To Kagaku Ryoho. 1992 Feb;19(2):178-83. Japanese.

PMID:
1371045
20.

From the outside looking in.

Moayedi Y, Bunce PE, Sade S, Ghazarian D, Gold WL.

Am J Med. 2012 May;125(5):457-60. doi: 10.1016/j.amjmed.2011.10.021. Epub 2012 Feb 22. No abstract available.

PMID:
22365025
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk